This story was originally published in ProPublica, a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story ...

Four in 10 Minnesotans who contracted COVID-19 reported in a new state survey that they struggled with lingering health ...

The latest round of the COVID inquiry focuses on vaccines and anti-viral treatment across the UK. Today we hear from several ...

The latest round of the COVID inquiry focuses on vaccines and anti-viral treatment across the UK. Today we're hearing ...

A study found that some long COVID patients who took Paxlovid saw improvement. But experts said the research isn't enough to ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

Your trendy health cure may not only be useless, it could also land you in the ER. As a growing number of people eschew ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

FOX 13's Lloyd Sowers reports on the FDA approving OneBlood's High Titer COVID-19 convalescent plasma treatment for immunocompromised patients.

Winter also marks the height of the respiratory virus season, a period of sniffles, sneezes, congestion, fever and other ...

Racial discrimination, bullying, sexism and other forms of discrimination have also been shown to increase the risk for ...